When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Prediction market on kalshi. If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.

24h Volume: $1.97. Liquidity: $156.69. Resolves: 3/8/2027.